Genomic landscape associated with potential response to anti-CTLA-4 treatment in cancers
There is an urgent need to identify predictive markers for selecting responders to immunotherapy. Here, the authors describe a transcriptional predictor of immunotherapy response and assess it in genomic data from ~ 10,000 human tissues across 30 different cancer types.
Guardado en:
Autores principales: | Chan-Young Ock, Jun-Eul Hwang, Bhumsuk Keam, Sang-Bae Kim, Jae-Jun Shim, Hee-Jin Jang, Sarang Park, Bo Hwa Sohn, Minse Cha, Jaffer A. Ajani, Scott Kopetz, Keun-Wook Lee, Tae Min Kim, Dae Seog Heo, Ju-Seog Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a7dbe118f55479d9642734712ad0d61 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment
por: So Yeon Oh, et al.
Publicado: (2021) -
Clinical pattern of failure after a durable response to immune check inhibitors in non-small cell lung cancer patients
por: Ja Yoon Heo, et al.
Publicado: (2021) -
Comparison of prognostic genomic predictors in colorectal cancer.
por: Yun-Yong Park, et al.
Publicado: (2013) -
Effect of Deformation Structure of AISI 316L in Low-Temperature Vacuum Carburizing
por: Hyunseok Cheon, et al.
Publicado: (2021) -
Co-Administration of Vonoprazan, Not Tegoprazan, Affects the Pharmacokinetics of Atorvastatin in Healthy Male Subjects
por: Sejung Hwang, et al.
Publicado: (2021)